FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

US Pharmaceuticals Medline Remedy Essential Barrier Skin Recall

Medline Remedy Essential Barrier Skin Protectant Ointment (petrolatum 59%) packaged in…

US Pharmaceuticals Inc. · Belleville, NJ

Risk level
Class II
Reported by FDA
Feb 13, 2019
Recall ID
D-0427-2019
Check your lot numberHow we source this data

Summary

US Pharmaceuticals recalled Medline Remedy Essential Barrier Skin starting Dec 7, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0427-2019 on Feb 13, 2019. Reason: GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample. Status: Terminated.

Why it was recalled

GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample

Product description

Medline Remedy Essential Barrier Skin Protectant Ointment (petrolatum 59%) packaged in a) 2 oz tubes (NDC 53329-302-14) and b) 6 oz tubes (NDC 53329-302-41), Medline Industries Inc., Manufactured for Medline Industries Inc., Mundelien, IL 60060.

Lot numbers, UPCs & expiration codes

Lot # a) and b): 44G17, Exp. 05/2019

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0427-2019
Classification
Class II
Status
Terminated
Recall initiated
Dec 7, 2018
FDA report date
Feb 13, 2019
Quantity
7020 units
Recall type
Voluntary: Firm initiated
Recalling firm
US Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0427-2019, exactly as published.

Show all FDA fields
City
Belleville
State
NJ
Status
Terminated
Country
United States
Event ID
81784
Address
681 Main St Ste 27
Code information
Lot # a) and b): 44G17, Exp. 05/2019
Postal code
07109-3471
Report date
Feb 13, 2019
Product type
Drugs
Recall number
D-0427-2019
Classification
Class II
Recalling firm
US Pharmaceuticals Inc.
Product quantity
7020 units
Termination date
Nov 6, 2023
Reason for recall
GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample
Voluntary / mandated
Voluntary: Firm initiated
Product description
Medline Remedy Essential Barrier Skin Protectant Ointment (petrolatum 59%) packaged in a) 2 oz tubes (NDC 53329-302-14) and b) 6 oz tubes (NDC 53329-302-41), Medline Industries Inc., Manufactured for Medline Industries Inc., Mundelien, IL 60060.
Distribution pattern
Nationwide within the United States
Recall initiation date
Dec 7, 2018
Initial firm notification
Letter
Center classification date
Feb 4, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0427-2019, published Feb 13, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls